A recent study showed that IGF2BP2 promotes HNSCC cell migration and invasion via the epithelial-mesenchymal transition process in vitro, and knockdown of IGF2BP2 significantly inhibited lymphatic metastasis and lymphangiogenesis in vivo [40]. The gene discussed is IGF2BP2; the disease is head and neck squamous cell carcinoma.